中文(简体)
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

QL Block With Exparel in Colectomy

只有注册用户可以翻译文章
登陆注册
链接已保存到剪贴板
状态招聘中
赞助商
Duke University
合作者
Pacira Pharmaceuticals, Inc

关键词

抽象

The purpose of this study is to determine if using a different type of injection of local anesthestic (pain medicine) in between the muscle layers of the abdominal wall (called a quadratus lumborum block) will improve pain control and be easier to manage after surgery than the current standard of care epidural (spinal injection) pain relief for patients undergoing laparoscopy colectomy.

描述

Participants in this study will receive exparel via an abdominal muscle nerve block procedure immediately prior to their operation. Participants will be in this study for 96 hours following surgery, which is typically 3 days. During participation, the study staff will review participant's electronic health records for pain scores and pain medication needs.

Participants that receive the quadratus lumborum block, may experience improved pain control and/or reduced side effects compared to the epidural pain relief option, but it is not known yet whether this will be the case.

The most common risk is being sore in the flank where the block was placed. Other risks of the block rarely occur (less than .5-1%), these can include infection, allergy to the local anesthetic, bleeding, damage to the nerve, seizures, abnormal heart rhythms, and cardiac arrest.

日期

最后验证: 06/30/2020
首次提交: 01/30/2019
提交的预估入学人数: 01/30/2019
首次发布: 01/31/2019
上次提交的更新: 07/09/2020
最近更新发布: 07/13/2020
实际学习开始日期: 10/30/2019
预计主要完成日期: 03/31/2021
预计完成日期: 04/07/2021

状况或疾病

Laparotomy
Colectomy

干预/治疗

Drug: Quadratus lumborum block

Other: Thoracic epidural analgesia

相 4

手臂组

干预/治疗
Experimental: Quadratus lumborum block
Bilateral administration on each side of 30 ml aliquot containing 10 ml of liposomal bupivacaine (133 mg) and 20 ml of 0.25% bupivacaine (50 mg) in the fascial plane between the QL and psoas major muscles.
Drug: Quadratus lumborum block
Bilateral administration on each side of 30 ml aliquot containing 10 ml of liposomal bupivacaine (133 mg) and 20 ml of 0.25% bupivacaine (50 mg) in the fascial plane between the QL and psoas major muscles.
Other: Thoracic epidural analgesia
Historical cohort that received thoracic epidural analgesia.
Other: Thoracic epidural analgesia
Historical cohort that received thoracic epidural analgesia

资格标准

有资格学习的年龄 18 Years 至 18 Years
有资格学习的性别All
接受健康志愿者
标准

Inclusion Criteria:

- Patients scheduled for elective, laparoscopic colonic resection by one of three surgeons: Drs. Thacker, Mantyh or Migaly. These surgeons perform this procedure in the same manner

- Age 18-85 years

- American Society of Anesthesiologists (ASA) Physical Class I-III

- BMI 18-35 kg/m^2

Exclusion Criteria:

- Inability to consent

- Inability to speak English

- Pregnancy

- Emergency surgery

- Contraindications to regional blockade: coagulopathy or bleeding diathesis, local infection, allergy to local anesthetics

- Allergies/intolerances/contraindications to any of the multimodal agents (acetaminophen, gabapentin, ketorolac)

- Daily opioid equivalent use of 30 mg of morphine or greater at time of consent

- History of drug or alcohol abuse

- Rheumatoid arthritis

- Uncontrolled anxiety, schizophrenia or other psychiatric disorder that, in the opinion of the investigator, may interfere with the study assessments of compliance

结果

主要结果指标

1. Cumulative opioid consumption over 48 hours [Opioid consumption from administration of Exparel to 48 hours post-administration]

Opioid consumption from administration of Exparel to 48 hours post-administration

其他成果措施

1. 11-point Numeric Rating Scale (NRS-11) [30 minutes after arrival to Post-Anesthesia Care Unit (PACU), and at 8 hours, 24 hours, 36 hours, 48 hours, 72 hours, 96 hours, 120 hours, 144 hours and 168 hours post Exparel administration]

Two measures will be taken with each assessment, one at rest and one with coughing. (11-point scale: 10=worst pain imaginable, 0= no pain)

2. Block success [30 minutes after arrival to PACU, 8 hours, 24 hours, 36 hours, 48 hours and 72 hours post Exparel administration]

Presence of demonstrable sensory block over 4 points on the abdomen (one in each of the 4 quadrants), as tested by response to pinprick. Subjects will be asked to report whether the stimulus feels "sharp" or "dull", indicating block failure and success respectively.

3. Adverse Events [From administration of Exparel through 168 hours post Exparel administration]

Subjects will be evaluated for potential adverse events related to the block including evidence of hematoma, infection, unexpected sensory or motor deficit, local anesthetic systemic toxicity, as well as transient weakness of the hip flexor muscles (a known possible side-effect of QL block).

4. Satisfaction with postoperative pain control [From administration of Exparel through 48 hours post Exparel administration]

Overall subject satisfaction with pain control will be recorded on postoperative day 0 and 1 (11-point scale: 10=highly satisfied, 0=completely unsatisfied)

5. Hospital length of stay [From administration of Exparel through hospital discharge]

Measured both by raw length of stay and by time to achieving "discharge readiness", defined by the presence of 3 criteria: a pain score of 3 or less with ambulation, no opioids required in the preceding 6 hours, and the ability to perform self-care (go to the toilet, dress, and shower).

6. Incidence of opioid-related adverse events [From administration of Exparel through 168 hours post Exparel administration]

Incidence of nausea, vomiting, ileus, constipation, orthostasis, pruritis, urinary retention, respiratory depression

7. Time to first mobilization [From time of arrival in PACU through first mobilization]

Time to first mobilization

8. Cost [From time of arrival in PACU through 96 hours post Exparel administration]

Hospital costs including pharmacy-related costs, costs due to opioid-related adverse events, the cost associated with nursing interventions and drugs to treat opioid-related adverse events, and overall hospital admission costs will be calculated.

9. Sleep Quality [From administration of Exparel through 168 hours post Exparel administration]

Two measures will be taken for sleep quality assessment. How much did pain interfere with falling asleep ( 0= no interference, 10= completely interferes). How much did pain interfere with staying asleep (0= no interference, 10= completely interferes). Measures will be taken once daily from POD 1 to POD 7 (approximately 168hrs. after surgery).

加入我们的脸书专页

科学支持的最完整的草药数据库

  • 支持55种语言
  • 科学支持的草药疗法
  • 通过图像识别草药
  • 交互式GPS地图-在位置标记草药(即将推出)
  • 阅读与您的搜索相关的科学出版物
  • 通过药效搜索药草
  • 组织您的兴趣并及时了解新闻研究,临床试验和专利

输入症状或疾病,并阅读可能有用的草药,输入草药并查看所使用的疾病和症状。
*所有信息均基于已发表的科学研究

Google Play badgeApp Store badge